Safety of new medicines in young children
- PMID: 21836178
- PMCID: PMC3198508
- DOI: 10.1136/archdischild-2011-300450
Safety of new medicines in young children
Conflict of interest statement
Comment on
-
Safety concerns of angiotensin II receptor blockers in preschool children.Arch Dis Child. 2011 Sep;96(9):881-2. doi: 10.1136/archdischild-2011-300172. Epub 2011 Jun 19. Arch Dis Child. 2011. PMID: 21690106
References
-
- Sammons HM, Gray C, Hudson H, et al. Safety in paediatric clinical trials–a 7-year review. Acta Paediatr 2008;97:474–7 - PubMed
-
- de Vries TW, van Roon EN. Low quality of reporting adverse drug reactions in paediatric randomised controlled trials. Arch Dis Child 2009;95:1023–6 - PubMed
-
- Tsang R, Colley L, Lynd LD. Inadequate statistical power to detect clinically significant differences in adverse event rates in randomized controlled trials. J Clin Epidemiol 2009;62:609–16 - PubMed
-
- Sutherland JM. Fatal cardiovascular collapse of infants receiving large amounts of chloramphenicol. Am J Dis Child 1959;97:13–19 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical